Gotowe bibliografie tematyczne / Anti-Sars-Cov-2

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Anti-Sars-Cov-2”

Autor: Grafiati
Data publikacji: 25 stycznia 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anti-Sars-Cov-2”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Anti-Sars-Cov-2"

1

Lippi, Giuseppe, Gian Luca Salvagno, Brandon M. Henry, Laura Pighi, Simone De Nitto, and Gianluca Gianfilippi. "Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination." Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 3, no. 1 (2021): 39–43. http://dx.doi.org/10.1515/almed-2021-0086.

Pełny tekst źródła
Streszczenie:
Abstract Objectives This article aims to summarize the 6-month variation of a vast array of anti-SARS-CoV-2 antibodies in recipients of BNT162b2 mRNA-based vaccination. Methods The study population consisted of 84 baseline SARS-CoV-2 seronegative healthcare employees (median age 45 years, 53.6% females), receiving mRNA-based BNT162b2 primary vaccination cycle. Blood was collected before the first and second BNT162b2 vaccine doses, as well as 1, 3 and 6 months afterwards. The serum titers of the following anti-SARS-CoV-2 antibodies were assayed: total anti-RBD (receptor binding domain), anti-sp
Style APA, Harvard, Vancouver, ISO itp.
2

Geanes, Eric S., and Todd Bradley. "Differences between autoantibodies induced by SARS-CoV-2 infection and Pfizer-BioNTech SARS-CoV-2 vaccination." Journal of Immunology 208, no. 1_Supplement (2022): 65.15. http://dx.doi.org/10.4049/jimmunol.208.supp.65.15.

Pełny tekst źródła
Streszczenie:
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can induce severe disease and lead to hospitalization and/or death in some subpopulations of patients. The underlying mechanisms of disease severity between individuals remain unclear. Recently, autoantibodies have been detected after severe SARS-CoV-2 infection, including anti-idiotypic IgM antibodies targeting ACE2, the receptor for SARS-CoV-2. In this study, we examined autoantibody differences within hospitalized patients with severe SARS-CoV-2 infection, individuals with previous SARS-CoV-2 infection (seroposi
Style APA, Harvard, Vancouver, ISO itp.
3

Furukawa, Hiroshi, Shomi Oka, Takashi Higuchi, et al. "Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan." Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 16 (January 2022): 117954842210754. http://dx.doi.org/10.1177/11795484221075492.

Pełny tekst źródła
Streszczenie:
OBJECTIVES Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Serological testing for anti-SARS-CoV-2 nucleocapsid (N) antibodies (Abs) and anti-SARS-CoV-2 spike (S) Abs is performed to detect prior COVID-19 infection. It is still controversial which antibodies are the most sensitive and specific, and which can be detected earliest after infection. Here, we evaluated the results of serological tests of anti-SARS-CoV-2 N and S Abs in Japan. METHODS Symptomatic COVID-19 patients (n = 84) and control patients with rheumatoid arthriti
Style APA, Harvard, Vancouver, ISO itp.
4

Siddi, Mariana, Paolo Molinari, Carlo Maria Alfieri, et al. "Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not)." Pathogens 11, no. 5 (2022): 572. http://dx.doi.org/10.3390/pathogens11050572.

Pełny tekst źródła
Streszczenie:
Background: The evidence in the medical literature regarding the prevalence of antibody towards SARS-CoV-2 in patients with chronic kidney disease is limited, particularly among those at the pre-dialysis stage. Aim: We have prospectively performed a cohort study at a third-level university hospital to evaluate frequency and risk factors for anti-SARS-CoV-2-positive serology among chronic kidney disease patients. Methods: We have tested a cohort of consecutive outpatients with chronic kidney disease on regular follow-up at a major metropolitan hospital, during the SARS-CoV-2 outbreak in Italy.
Style APA, Harvard, Vancouver, ISO itp.
5

Herroelen, Pauline H., Geert A. Martens, Dieter De Smet, Koen Swaerts, and An-Sofie Decavele. "Humoral Immune Response to SARS-CoV-2." American Journal of Clinical Pathology 154, no. 5 (2020): 610–19. http://dx.doi.org/10.1093/ajcp/aqaa140.

Pełny tekst źródła
Streszczenie:
Abstract Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology tests are clinically useful to document prior SARS-CoV-2 infections. Data are urgently needed to select assays with optimal sensitivity at acceptable specificity for antibody detection. Methods A comparative evaluation was performed of 7 commercial SARS-CoV-2 serology assays on 171 sera from 135 subjects with polymerase chain reaction–confirmed SARS-CoV-2 infection (71 hospitalized patients and 64 paucisymptomatic individuals). Kinetics of IgA/IgM/IgG seroconversion to viral N and S protein epitopes were
Style APA, Harvard, Vancouver, ISO itp.
6

Germer, Matthias, Viola Marschall, Veit Braun, Jörg Schüttrumpf, and Matthias Germer. "Rising anti-SARS-CoV-2 titer in a human immunoglobulin preparation." International Journal of Blood Transfusion and Immunohematology 13, no. 1 (2023): 1–8. http://dx.doi.org/10.5348/100076z02ch2023ra.

Pełny tekst źródła
Streszczenie:
Aims: To assess potential changes of pharmacological activities of a novel normal immunoglobulin for intravenous administration from pooled normal plasma (IVIG). Methods: We assessed the impact of the SARS-CoV-2 pandemic on the level and activity of pathogen-specific antibodies in IVIG batches produced before and during the pandemic. Antibody levels were determined by immunoassays. The functional activity of SARS-CoV-2 antibodies was determined by in vitro neutralization. Results: In the IVIG, the antibody titer against bacteria, different viruses and a fungus were found to be in a defined ran
Style APA, Harvard, Vancouver, ISO itp.
7

Häusler, Sebastian, Marco Weigl, Andreas Ambrosch, Rudolf Gruber, Birgit Seelbach-Göbel, and Sara Fill Malfertheiner. "Peripartal anti-SARS-CoV-2-IgA/IgG in asymptomatic pregnant women during regional SARS-CoV-2-outbreak." Journal of Perinatal Medicine 49, no. 6 (2021): 709–16. http://dx.doi.org/10.1515/jpm-2021-0001.

Pełny tekst źródła
Streszczenie:
Abstract Objectives The Severe Acute Respiratory Distress Corona Virus 2 (SARS-CoV-2) pandemic poses special challenges for the society and especially the medical staff. Even if a rather mild course is assumed among pregnant women the measures to prevent transmission of the infection are of outstanding importance. Methods To screen asymptomatic pregnant women during admission to our university maternal hospital we focused on anti-SARS-CoV-2-specific IgG and IgA antibody responses. Hundred and fifty one women admitted to the hospital for childbirth or caesarean delivery were included. In case o
Style APA, Harvard, Vancouver, ISO itp.
8

Kittel, Maximilian, Romy Eichner, Sihem Aida, et al. "Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application." Viruses 14, no. 8 (2022): 1662. http://dx.doi.org/10.3390/v14081662.

Pełny tekst źródła
Streszczenie:
Background: During the last two years, a variety of assays for the serological detection of antibodies to the new SARS-CoV-2 virus have been launched and used as part of standard care in many laboratories. The pace with which these tests have been introduced into routine care emphasizes the importance of quality measures for analytical methods, particularly with regard to the implications of results for clinical and epidemiologic decisions. Accuracy, reliability and comparability of analytical test results are thus essential, and here external quality assessment (EQA) is the most important qua
Style APA, Harvard, Vancouver, ISO itp.
9

Brice, David, and Maureen A. McGargill. "Coronavirus spike protein vaccination history affects SARS-CoV-2 receptor-binding domain-specific memory response in a mouse model." Journal of Immunology 210, no. 1_Supplement (2023): 235.19. http://dx.doi.org/10.4049/jimmunol.210.supp.235.19.

Pełny tekst źródła
Streszczenie:
Abstract Background: Previous exposure to human common cold coronaviruses (hCCCoVs) has been shown to affect immune responses to SARS-CoV-2. Since most humans have been infected with different hCCoVs throughout their lives, determining exactly how previous immunity to hCCoVs affects anti-SARS-CoV-2 responses, especially to the Spike (S) protein and its receptor-binding domain (RBD), has proven difficult. We, therefore, used a mouse model to investigate how exposure to different coronavirus S alters the immune response to SARS-CoV-2 S vaccination. Methods: C57BL/6 mice were vaccinated intramusc
Style APA, Harvard, Vancouver, ISO itp.
10

Notrisia Rachmayanti, Bastiana Bermawi, and Diyan Wahyu Kurniasari. "Pemeriksaan Skrining Covid-19 Kepada Pegawai Laboratorium Rumah Sakit Islam Surabaya Jemursari di Masa Pandemi." SEMINAR NASIONAL PENGABDIAN KEPADA MASYARAKAT 2021 1, no. 1 (2022): 1094–99. http://dx.doi.org/10.33086/snpm.v1i1.925.

Pełny tekst źródła
Streszczenie:
COVID-19 telah menjadi pandemi sejak Januari 2020. COVID-19 disebabkan oleh SARS-CoV 2 yang menyebar melalui droplet dan airborne sehingga petugas kesehatan rentan tertular. RSI Surabaya Jemursari telah merawat pasien COVID-19 dan melakukan pemeriksaan PCR SARS-CoV 2 sehingga skrining rutin menjadi hal yang sangat perlu dilakukan pada pegawai laboratorium. Kegiatan dilaksanakan dengan mengidentifikasi pegawai laboratorium RSI Surabaya Jemursari untuk kemudian dilakukan anamnesis dan pemeriksaan fisik. Kemudian dilakukan pengambilan swab nasofaring untuk pemeriksaan antigen serta pengambilan da
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Anti-Sars-Cov-2"

1

NGUYEN, HOANG OANH. "ANTI-INFLAMMATORY PROPERTIES OF PDE4 INHIBITION IN SARS-COV-2-ACTIVATED HUMAN DENDRITIC CELLS." Doctoral thesis, Università degli studi di Brescia, 2022. http://hdl.handle.net/11379/555422.

Pełny tekst źródła
Streszczenie:
È stato dimostrato che la risposta immunitaria disfunzionale e l’iper-infiammazione con conseguente tempesta citochinica giocano un ruolo chiave nello sviluppo di forme severe di malattia da Coronavirus 2019 (COVID-19). Tale condizione clinica suggerisce che l’eccessiva risposta immunitaria innata potrebbe scatenare una patologia immunitaria virus-dipendente. In questo lavoro, viene descritto un nuovo meccanismo di attivazione delle cellule dendritiche da parte del virus SARS-CoV-2. Nello specifico, sequenze di RNA del genoma virale sono in grado di attivare dei recettori endosomiali, in parti
Style APA, Harvard, Vancouver, ISO itp.
2

Giraudet, Rémi. "Développement d'approches de suppression des épitopes T d'anticorps et de VHH pour réduire leur risque d'immunogénicité." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASQ067.

Pełny tekst źródła
Streszczenie:
Dans un contexte où l'immunogénicité des biothérapies, en particulier des anticorps thérapeutiques, constitue un obstacle majeur à leur efficacité clinique, cette thèse explore des stratégies pour réduire ce risque, en se concentrant sur trois axes principaux : le développement d'outils in silico pour concevoir des mutations déimmunisantes, la déimmunisation de l'adalimumab et l'évaluation des réponses immunitaires CD4+ spécifiques aux VHH.Les outils in silico actuellement disponibles se concentrent soit sur la prévision de la liaison aux molécules HLA-II soit sur l'évaluation de l'humanité de
Style APA, Harvard, Vancouver, ISO itp.
3

CIPOLLONE, CLAUDIA. "Studio della risposta anticorpale alla vaccinazione anti-SARS-CoV-2 in una popolazione di operatori sanitari di una ASL del Centro Italia." Doctoral thesis, Università degli Studi dell'Aquila, 2022. http://hdl.handle.net/11697/192080.

Pełny tekst źródła
Streszczenie:
La diffusione, nel dicembre 2019, di un nuovo coronavirus, SARS-CoV-2, ha avuto conseguenze disastrose a livello globale. La proteina “spike” di SARS-CoV-2, ed in particolare il suo sito di legame per il recettore (RBD) è risultata essere, il target più importante contro cui venivano prodotti gli anticorpi dei soggetti che avevano contratto l’infezione. Per questo motivo, diverse tipologie di vaccino hanno mirato ad indurre la produzione di anticorpi diretti contro il dominio RBD. BNT162b2 Pfizer/BioNTech è stato il vaccino di scelta per la somministrazione agli operatori sanitari in Italia; i
Style APA, Harvard, Vancouver, ISO itp.
4

de, Assis Marcelo. "Desenvolvimento de Novas Tecnologias Baseadas em Materiais Biocidas." Doctoral thesis, Universitat Jaume I, 2021. http://dx.doi.org/10.6035/14104.2021.793638.

Pełny tekst źródła
Streszczenie:
a-Ag2WO4, which already shows biocidal activity, when modified by electrons or femtosecond laser increases its biocidal activity up to 32x, against resistant bacteria and fungi due to the generated metal-semiconductor interface. In addition, this modification makes this interface selective for combating bladder cancer cells (MB49), versus healthy cells (BALB/3T3), using model mouse cells. Ag/SiO2 immobilized on ethylene vinyl acetate was another studied interface which showed 99.99% inhibition of bacteria and fungi, besides eliminating in just 2 minutes over 99% of SARS-CoV-2 virus replicates.
Style APA, Harvard, Vancouver, ISO itp.
5

Al, Ibrahim Malak. "Anti-coronavirus potential of halophytes and invasive plants from Northern France : discovery of active terpenoids from Hippophae rhamnoides and Senecio inaequidens." Electronic Thesis or Diss., Université de Lille (2022-....), 2024. http://www.theses.fr/2024ULILS003.

Pełny tekst źródła
Streszczenie:
Les coronavirus sont responsables de maladies des voies respiratoires bénignes à graves chez l’Homme. Malgré des progrès significatifs dans la compréhension de la pathologie et de la gestion clinique des coronavirus, ces maladies virales restent un problème de santé publique en raison d’épidémies récurrentes provoquées par l’émergence de variants, d’un accès inégal aux traitements contre la COVID-19, de taux de vaccination inadéquats et de populations à haut risque non vaccinées. Il est donc impératif de développer des solutions antivirales spécifiques et abordables pour contrôler et prévenir
Style APA, Harvard, Vancouver, ISO itp.
6

Lu, Ping-Hsun, and 呂秉勳. "1. Synthesis and Anti-SARS-coV Activity of promazine analogues. 2. Synthesis and Anti-Cancer Activity of 3-Phenoxy Substituted Indole Analogues." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/73603118436885853669.

Pełny tekst źródła
Streszczenie:
碩士<br>國立清華大學<br>化學系<br>93<br>Abstract The thesis consists of two parts: the first part is concerned with the synthesis and bioassay of promazine analogues and the second part describes the synthesis and anti-cancer activity of 3-phenoxy substituted indole analogues. The first part : The global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. An in-house chemical library consisting of 800 marketed drugs was evaluated for anti-SARS-CoV activities. We began our drug screening using porcine transmissible gastroenteritis virus (TGEV) as the sur
Style APA, Harvard, Vancouver, ISO itp.
7

Gutiérrez, Laura. "Evaluación del desempeño analítico de dos ensayos inmunológicos de diferente configuración para la detección de anticuerpos anti SARS-CoV-2." Doctoral thesis, 2021. http://hdl.handle.net/11086/21904.

Pełny tekst źródła
Streszczenie:
Trabajo Integrador Final (Especialista en Virología) - - Universidad Nacional de Córdoba. Facultad de Ciencias Químicas, 2021<br>Calcular la sensibilidad, especificidad, valor predictivo positivo y valor predictivo negativo de dos ensayos inmunológicos de diferente configuración (CMIA y ELISA) para la detección de anticuerpos anti SARS CoV 2 Evaluar la concordancia analítica entre los diferentes ensayos.<br>2023-11-30<br>Fil: Gutiérrez, Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; Argentina.<br>Fil: Barbás, María G. Gobierno de la Provincia de Córdoba. Ministerio de
Style APA, Harvard, Vancouver, ISO itp.
8

Branco, Filipa Saraiva e. Silva Rodrigues. "Influência e caracterização do movimento antivacinação nas redes sociais em Portugal." Master's thesis, 2021. http://hdl.handle.net/10362/131416.

Pełny tekst źródła
Streszczenie:
Introdução: A resposta à pandemia provocada pelo vírus SARS-CoV-2 e as vacinas desenvolvidas têm encontrado obstáculos criados pela disseminação de notícias falsas e conspirações propagadas pelo movimento antivacinação nas redes sociais. Desta forma, a hesitação vacinal poderá ter contornos nunca antes vistos, em Portugal, até ao momento. Métodos: Este estudo analisa as publicações, comentários e membros do grupo do Facebook “Anti-VAX Portugal” desde 10 de abril a 10 de outubro de 2020, no decorrer da pandemia. Foi também aplicado um inquérito por questionário online, onde se procura compreend
Style APA, Harvard, Vancouver, ISO itp.

Książki na temat "Anti-Sars-Cov-2"

1

Chen, Jen-Tsung. Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Chen, Jen-Tsung, ed. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-3664-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Anti-Sars-Cov-2 Activity of Flavonoids. CRC Press LLC, 2024.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Roviello, Giovanni N., and Caterina Vicidomini, eds. Potential Anti-SARS-CoV-2 Molecular Strategies. MDPI, 2023. http://dx.doi.org/10.3390/books978-3-0365-6962-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Springer, 2023.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Anti-Sars-Cov-2"

1

Gurung, Arun Bahadur, and Atanu Bhattacharjee. "Anti-SARS-CoV-2 Activity of Flavones." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Esmaealzadeh, Niusha, Roodabeh Bahramsoltani, and Roja Rahimi. "Green Tea Catechins against SARS-CoV-2." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Dalli, Mohammed, Salah-eddine Azizi, Nour Elhouda Daoudi, et al. "Traditional Herbal Medicines for COVID-19." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Jayashree, S., K. Sonia, G. Mayakkannan, S. Shruthi, S. Aruna Sharmili, and Sekar Vijayakumar. "Isoflavonoids As Bioactive Molecules against SARS-CoV-2." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Rajak, Naina, Vipendra Kumar Singh, and Neha Garg. "Molecular Insights into Anti-SARS-CoV-2 Activity of Catechins against Protein Targets for COVID-19 Management." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Chakraborty, Pallab, Krishnendu Acharya, Joy Sarkar, Solomon Habtemariam, Javad Sharifi-Rad, and William C. Cho. "Antiviral Activities of Naringenin and Its Derivatives as Adjuvant Treatment against SARS-CoV-2 Infections." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ghoran, Salar Hafez, Fatemeh Taktaz, Pouya Alipour, et al. "Anti-SARS-CoV-2 Activity of Flavonols and Their Glycosylated Derivatives." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Kashyap, Piyush, Mamta Thakur, Rhythm Kalsi, et al. "Molecular Aspects on Anti-SARS-CoV-2 Activity of Flavonols." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Mishra, Amaresh, Km Shivangi, Manju Yadav, et al. "Plant-Derived Polyphenols in Modulating the Immune Response against COVID-19." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Yasri, Sora, and Viroj Wiwanitkit. "Traditional Medicines and Functional Foods in Indochina for COVID-19 Management." In Anti-SARS-CoV-2 Activity of Flavonoids. CRC Press, 2024. http://dx.doi.org/10.1201/9781003433200-21.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Anti-Sars-Cov-2"

1

Mcelvaney, O. F., T. Asakura, S. Meinig, et al. "Protease-Anti-Protease Compartmentalization in SARS-CoV-2 ARDS: Therapeutic Implications." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3629.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Siqueira, JR, TS Pinho, EEI Flores, TFS Lima, MLL Moreira, and EM Carvalho. "ANÁLISE DA ESTABILIDADE DA IGG ANTI-SARS-COV-2 APÓS ARMAZENAMENTO SOB ULTRA REFRIGERAÇÃO." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.6156.

Pełny tekst źródła
Streszczenie:
Objetivo: No contexto da pandemia do Sars-CoV-2, o armazenamento de amostras biológicas em biorrepositórios para futuros estudos dos seus impactos na população traz a necessidade do conhecimento sobre a estabilidade de analitos relacionados. A IgG anti-Sars-CoV-2 pode ser utilizada futuramente em estudos de soroprevalência e soroconversão durante as fases da pandemia. No teste comercial para dosagem de IgG anti-Sars-CoV-2 (Abbott), o prazo estabelecido em bula para armazenamento ≤ -20ºC é de 30 dias. Entretanto, para estudos posteriores, avaliamos a estabilidade desse analito em soro humano ma
Style APA, Harvard, Vancouver, ISO itp.
3

Adi, Wihan, Dhruv Biswas, Miriam A. Shelef, and Filiz Yesilkoy. "Multiplexed COVID-19 Antibody Quantification from Human Sera Using Label-free Nanoplasmonic Biosensors." In Applied Industrial Spectroscopy. Optica Publishing Group, 2022. http://dx.doi.org/10.1364/ais.2022.jm2e.4.

Pełny tekst źródła
Streszczenie:
Serological assays can reveal immune status against COVID-19 informing individual and public healthcare decisions. We report a multiplexed and label-free nanoplasmonic biosensor that can discriminate healthy from convalescent samples with high sensitivity (95%) and specificity (100%) based on anti-SARS-CoV-2 antibody quantification. Our results show high concordance (R~ 0.87) with commercial assays in detecting anti-SARS-CoV-2 antibodies.
Style APA, Harvard, Vancouver, ISO itp.
4

Uzun, G., K. Althaus, B. Luz, M. Wolf, H. Henkes, and T. Bakchoul. "Anti-PF4 antibodies after SARS-CoV-2 vaccines: long term follow-up." In GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760583.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Numata-Nakamura, M., R. Bowen, and D. R. Voelker. "Pulmonary Surfactant Phospholipids as Novel Anti-Virals Against SARS-CoV-2 Infection." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1196.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Almeida, Antonio L. de, and João B. L. Martins. "DFT study of Anti Sars-Cov-2 EIDD-1931 and EIDD-2801 molecular structures." In VIII Simpósio de Estrutura Eletrônica e Dinâmica Molecular. Universidade de Brasília, 2020. http://dx.doi.org/10.21826/viiiseedmol2020187.

Pełny tekst źródła
Streszczenie:
Scientists around the world are joining efforts in the study of the current SARS-CoV-2 virus and the Covid-19 disease. As a result, several compounds have been studied for the treatment of SARS-CoV-2, among them there are N4-hydroxycytidine prodrug (NHC; EIDD-1931), and EIDD-2801, that have shown antiviral activity against SARS-CoV-2. We have studied the structural and electronic properties of these molecules using B3LYP functional and aug-cc-pVDZ basis set.
Style APA, Harvard, Vancouver, ISO itp.
7

Sattarnezhad, Neda, Julia Sumera, Jamie McDonald, et al. "SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab (P10-5.012)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000204308.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Cui, Zeyu, Qing Liu, Mengmeng Fan, Dakuo He, and Yue Hou. "Determination of Anti-SARS-CoV-2 Activity of Compounds Based on Machine Learning." In 2022 International Conference on Information Technology, Communication Ecosystem and Management (ITCEM). IEEE, 2022. http://dx.doi.org/10.1109/itcem57303.2022.00021.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Sampaio, João Pedro Lima, Sarah Larissa Gomes Flores, Kidney de Oliveira Gomes Neves, et al. "Lisboaeflavanonol A: um flavonoide glicosilado com ação ANTI-SARS-CoV-2 in vitro." In XXXIII Congresso de Iniciação Científica. Even3, 2025. https://doi.org/10.29327/xxxiii-conic.1035494.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Elbashir, Israa, Aisha Aisha Nasser J. M. Al-Saei, Paul Thornalley, and Naila Rabbani. "Evaluation of antiviral activity of Manuka honey against SARS-CoV-2." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0113.

Pełny tekst źródła
Streszczenie:
Background and aims: In 2020 a global pandemic was declared caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The pandemic is still ongoing and continues to cause considerable mortality and morbidity world-wide and new variants of the virus are emerging. Rapid development and rollout of vaccines for SARS-CoV-2 is in progress to counter the pandemic but has been tempered by the emergence of new SARS-CoV-2 variants, many of which exhibit reduced vaccine effectiveness. To date there is no approved antiviral treatment for coronavirus disease 2019 (COVID-19). Several studies
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Anti-Sars-Cov-2"

1

Bailey, Jacob J., Andrew M. Morris, Sally Bean, et al. Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario. Ontario COVID-19 Science Advisory Table, 2021. http://dx.doi.org/10.47326/ocsat.2021.02.45.2.0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity. EMBL-EBI, 2022. http://dx.doi.org/10.6019/chembl4651402.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Anti-Sars-Cov-2” dla poszczególnych typów źródeł:
Artykuły w czasopismach
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii